'Low expression' diaporamas de présentation

Amino Acid Biosynthesis

Amino Acid Biosynthesis. Introduction. Essential (10) Arginine Histidine Isoleucine Leucine Lysine Methionine Phenylalanine Threonine Tryptophan Valine. Non-essential Alanine Asparagine Aspartate Cysteine Glutamate Glutamine Glycine Proline Serine Tyrosine.

1.78k views • 69 slides

Background

Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): Analysis of the phase III MAX study.

356 views • 18 slides

242 views • 11 slides

Foreign Gene Expression and Protein Production in Prokaryotes and Eukaryotes

Foreign Gene Expression and Protein Production in Prokaryotes and Eukaryotes. Prokaryotic Expression Systems Fusion Proteins Biofilms Secretion Eukaryotic Expression Systems Posttranslational modifications (PTMs). Prokaryotic Expression Systems.

316 views • 9 slides

Foreign Gene Expression and Protein Production in Prokaryotes and Eukaryotes

Foreign Gene Expression and Protein Production in Prokaryotes and Eukaryotes. Prokaryotic Expression Systems Fusion Proteins Biofilms Secretion Eukaryotic Expression Systems Posttranslational modifications (PTMs). Prokaryotic Expression Systems.

412 views • 9 slides

Interdepartmental Honours in Immunology project Activating Antigen Expression: In search of the stimulus for RskA

166 views • 6 slides

Carol Greider and Liz Blackburn (Cell 43:405, 1985)

Carol Greider and Liz Blackburn (Cell 43:405, 1985) A telomere-extending enzyme would solve the end-replication problem. But does one really exist? Seeking biochemical evidence of telomerase from Tetrahymena extracts Formation of the macronucleus includes extensive breaking

189 views • 4 slides

The MicroRNA-200 Family Regulates Non-Small Cell Lung Cancer Prognostic Markers in H1299

The MicroRNA-200 Family Regulates Non-Small Cell Lung Cancer Prognostic Markers in H1299. Supplementary Figures. Figure S1.

170 views • 3 slides

40

100%. 100%. 100%. 100%. 100%. 100%. 100%. 100%. 80%. 80%. 80%. 80%. 80%. 80%. 80%. 80%. 60%. 60%. 60%. 60%. 60%. 60%. 60%. 60%. 40%. 40%. 40%. 40%. 40%. 40%. 40%. 40%. 20%. 20%. 20%. 20%. 20%. 20%. 20%. 20%. 0%. 0%. 0%. 0%. 0%. 0%. 0%. 0%. 40 . 40 .

60 views • 1 slides

0.5

Low expression. High expression. 1.0. 0.75. 8. 3. 1. 2. 10. 7. 9. 11. 0.5. 4. 12. 14. Sensitvity (TPF). 5. 13. NBC-Hst. 0.25. NBC-Sst. FL. 6. CLL. 0. 0.25. 0.5. 0.75. 1.0. 1-Specificity (FPF). CLL. FL. High expression. 9. 2. P<0.001. 9. Low expression. 0.

120 views • 1 slides

0.5

Low expression. High expression. 1.0. 3. 0.75. 11. 13. 1. 2. 6. 5. 9. 14. 12. 10. 7. 0.5. Sensitvity (TPF). 8. 4. NBC-Hst. 0.25. NBC-Sst. FL. CLL. 0. 0.25. 0.5. 0.75. 1.0. 1-Specificity (FPF). CLL. FL. High expression. 0. 7. P<0.001. Low expression. 2. 11.

94 views • 1 slides